Ortho-McNeil™: News Center

Following are recent news releases issued by Ortho-McNeil™, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

For additional media resources, click here.

3/18/08		FDA ISSUES APPROVABLE LETTER FOR CEFTOBIPROLE FOR TREATMENT OF COMPLICATED SKIN INFECTIONS

3/6/08		FDA EXTENDS REVIEW TIMELINE FOR ADDITIONAL INDICATION FOR ANTIBIOTIC DORIBAX™

2/12/08		PRICARA™ RECALLS 25 mcg/hr DURAGESIC® (fentanyl transdermal system) CII PAIN PATCHES

1/23/08		New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets

10/15/07		FDA Approves DORIBAX™ for the Treatment of Complicated Intra-Abdominal and Complicated Urinary Tract Infections

10/08/07		New Data Show Ceftobiprole As Effective As Combination Therapy in Treating Patients with Diabetic Foot Infections

9/18/07		New Data Show Doripenem As Effective As Commonly Used Therapies In Treating Hospital-Acquired Peneumonias

9/18/07		New Data Show Ceftobiprole As Effective As Combination Therapy In Treating Patients With Complicated Skin Infections, Including MRSA

9/17/07		FDA Approves LEVAQUIN® Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis

7/19/07		Ortho-McNeil, Inc. Settles Patent Infringement Litigation Against Par/Kali

6/06/07		NEW DRUG APPLICATION SUBMITTED FOR INVESTIGATIONAL ANTIBIOTIC DORIPENEM

5/18/07		NEW DRUG APPLICATION SUBMITTED FOR NOVEL INVESTIGATIONAL ANTIBIOTIC CEFTOBIPROLE

5/11/07		Southern District Court of New York Rules Patent for ACIPHEX® Enforceable

1/30/07		Chronic Pain Up Almost 40 Percent Among U.S. Workers in Past Decade

12/19/06		New Study Shows IONSYS™ Rated Comparably as Method of Pain Control to Intravenous Patient-Controlled Morphine After Total Hip Replacement